DYAI,Dyadic International, Inc. | Healthcare

Healthcare

DYAI

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Dyadic International, Inc.DYAI

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States.

It utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus-like particles, protein antigens, ferritin nanoparticles, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins.

The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to demonstrate the safety in humans of a protein produced from C1-cell protein production platform.

It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; and strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U., as well as co-development and marketing agreement with Fermbox Bio Inc to design,Develop, and commercialize animal free alternative proteins and biomaterials The company was founded in 1979 and is headquartered in Jupiter, Florida.

Latest News >

Market Whales and Their Recent Bets on LRCX Options

Jul 12, 2024

High-rolling investors have positioned themselves bullish on Lam Research ( LRCX ) , and it's important for retail traders to take note. This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in LRCX often signals that someone has privileged information. Today, Benzinga's...

U.S. Inflation Drop Paves Way For Federal Reserve Rate Cuts: Will Cannabis Stocks Benefit?

Jul 12, 2024

The recent drop in U.S. inflation has sparked discussions about potential interest rate cuts by the U.S. Federal Reserve Bank. As inflation cools, investors are reconsidering their portfolios, with cannabis stocks emerging as a potential opportunity. Cooling Inflation Trends Inflation in the U.S. has decreased for three consecutive months, with a 0.1% decline from May to June. This marks the first...

Dow hits all-time high in broader market rally

Jul 12, 2024

July 12 (Reuters) - The Dow Jones Industrial Average scaled an intraday record high on Friday, playing catch-up with two other main U.S. indexes in recent broad-based market gains. The blue-chip 30-stock index was up 0.9% at 40,094.54 points, surpassing its previous intraday all-time high of 40,077.40 points hit in late May. So far this year, the Dow has risen...

Dow hits all-time high in broader market rally

Jul 12, 2024

(Reuters) - The Dow Jones Industrial Average scaled an intraday record high on Friday, playing catch-up with two other main U.S. indexes in recent broad-based market gains. The blue-chip 30-stock index was up 0.9% at 40,094.54 points, surpassing its previous intraday all-time high of 40,077.40 points hit in late May. So far this year, the Dow has risen 6.4%, underperforming...